3NYA
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 23-ID-D |
Synchrotron site | APS |
Beamline | 23-ID-D |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-11-19 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 1.0332 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 40.577, 75.730, 173.403 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.940 - 3.160 |
R-factor | 0.23479 |
Rwork | 0.232 |
R-free | 0.28962 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3d4s |
RMSD bond length | 0.008 |
RMSD bond angle | 1.045 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0088) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 3.350 |
High resolution limit [Å] | 3.160 | 3.160 |
Number of reflections | 8952 | |
<I/σ(I)> | 6.4 | 2.09 |
Completeness [%] | 92.1 | 88.9 |
Redundancy | 3.02 | 2.83 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 293 | 100 mM Bis-Tris Propane pH 6.6-6.8, 120 mM Na-tartrate, 3% 1,3 butanediol, 25-30% PEG 400, Lipidic Cubic Phase (LCP) Crystallization, temperature 293-295K | ||
1 | 293 | 100 mM Bis-Tris Propane pH 6.6-6.8, 120 mM Na-tartrate, 3% 1,3 butanediol, 25-30% PEG 400, Lipidic Cubic Phase (LCP) Crystallization, temperature 293-295K |